Physician profile

Pankaj Singhal

Gynecologic Oncology · Buffalo, NY

NPI 1437361037

$1,456.05

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$90.76

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Momentis Surgical INC. $984.00 2022
Glaxosmithkline, LLC. $117.99 2021
Tela Bio, INC. $90.24 2019
Myriad Women'S Health, INC. $62.19 2023 Myrisk
Abbvie INC. $58.70 2019
Eisai INC. $34.52 2019-2021
Hologic Sales and Service, LLC $31.37 2022
Kerecis Limited $28.57 2024 Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose
Exeltis, USA INC. $20.58 2021
Tesaro, INC. $15.77 2019
Covidien Lp $12.12 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Pankaj Singhal

$1,456.05

in general payments reported 2019-2025

Years
2019-2024
Top company
Momentis Surgical INC.

https://glasscript.com/doctor/156338/pankaj-singhal

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.